Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPEX/4172 stock hub

TPEX/4172 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4172is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.5B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4172

In the news

Latest news · TPEX/4172

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-36.1

P25 -16.2P50 0.3P75 9.8

ROIC-20.5

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4172 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

184

Groups with data

Currency

TWD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	34
Employees Change	0%
Employees Change Percent	0
Enterprise value	TWD 1.4B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TW0004172002
Last refreshed	2026-05-10
Market cap	TWD 1.5B
Price	TWD 14.3
Price currency	TWD
Rev Per Employee	2,029,029.41x
Sector	Healthcare
Sic	2836
Symbol	tpex/4172
Website	https://www.innopharmax.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.99%
EV Earnings	-7.61x
EV/FCF	-10.43x
EV/Sales	20.34x
FCF yield	-8.74%
P/B ratio	3.67x
P/S ratio	22.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-248.98%
EBITDA Margin	-246.38%
Gross margin	14.25%
Gross Profit	TWD 9.8M
Gross Profit Growth	-43.65%
Gross Profit Growth Q	-95.82%
Gross Profit Growth3 Y	-20.45%
Gross Profit Growth5 Y	-2.37%
Net Income	TWD -184.4M
Net Income Growth Years	0%
Pretax Margin	-262.21%
Profit Margin	-267.29%
Profit Per Employee	TWD -5.4M
ROA	-19.48
Roa5y	-11.3
ROCE	-40.98
ROE	-36.08
Roe5y	-22.02
ROIC	-20.48

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-8.18%
Cagr1y	-10.59%
Cagr3y	-7.05%
Cagr5y	-3.32%
EPS Growth Years	0
Revenue Growth	113.6x
Revenue Growth Q	144.69x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	25.88x
Revenue Growth5 Y	7.04x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.13
Assets	TWD 469M
Cash	TWD 146.3M
Current Assets	TWD 175.5M
Current Liabilities	TWD 49.8M
Debt	TWD 10.8M
Debt Equity	TWD 0.03
Debt FCF	TWD -0.08
Equity	TWD 419.2M
Interest Coverage	-448.5
Liabilities	TWD 49.8M
Long Term Assets	TWD 293.5M
Long Term Liabilities	TWD 0
Net Cash	TWD 135.5M
Net Cash By Market Cap	TWD 8.81
Net Cash Growth	-49.04%
Net Debt Equity	TWD -0.32
Tangible Book Value	TWD 413.9M
Tangible Book Value Per Share	TWD 3.85
WACC	4.74

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.52
Inventory Turnover	3.54
Net Working Capital	TWD -9.8M
Quick ratio	2.99
Working Capital	TWD 125.7M
Working Capital Turnover	TWD 0.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.36%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-57.42%
1Y total return	-10.58%
200-day SMA	17.48
3Y total return	-19.7%
50-day SMA	14.87
50-day SMA vs 200-day SMA	50under200
5Y total return	-15.51%
All Time High	91.49
All Time High Change	-84.37%
All Time High Date	2014-05-09
All Time Low	6.69
All Time Low Change	113.75%
All Time Low Date	2018-11-27
ATR	1.21
Beta	0.09
Beta1y	0.1
Beta2y	0.11
Ch YTD	-14.88
High	14.45
High52	23.75
High52 Date	2025-08-21
High52ch	-39.79%
Low	13.85
Low52	12.75
Low52 Date	2026-04-15
Low52ch	12.16%
Ma50ch	-3.83%
Price vs 200-day SMA	-18.21%
RSI	45.58
RSI Monthly	42.46
RSI Weekly	39.22
Sharpe ratio	0.11x
Sortino ratio	0.3
Total Return	-10.36%
Tr YTD	-14.31
Tr1m	1.06%
Tr1w	-6.54%
Tr3m	-10.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -171.8M
Operating margin	-249

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	81,014,885%
Net Borrowing	-4,569,000
Shares Insiders	2.06%
Shares Institutions	4.43%
Shares Out	107,575,500
Shares Qo Q	0.04%
Shares Yo Y	10.36%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -134.9M
Average Volume	775,845.4x
Bv Per Share	3.9
CAPEX	TWD -276,000
Ch10y	-59.36
Ch1m	1.06
Ch1w	-6.54
Ch1y	-11.18
Ch3m	-10.9
Ch3y	-20.78
Ch5y	-17.82
Ch6m	-18.05
Change	-1.04%
Change From Open	-1.04
Close	14.45
Days Gap	0
Depreciation Amortization	1,792,000
Dollar Volume	2,888,271.1
Earnings Date	2026-08-10
EBIT	TWD -171.8M
EBITDA	TWD -170M
EPS	TWD -1.71
F Score	2
FCF	TWD -134.5M
FCF EV Yield	-9.59x
FCF Per Share	TWD -1.25
Financing CF	-4,569,000
Fiscal Year End	December
Founded	1,994
Income Tax	TWD 3.5M
Investing CF	69,312,000
Is Primary Listing	1
Last Earnings Date	2025-12-05
Last Report Date	2025-12-31
Ma150	16.9
Ma150ch	-15.4%
Ma20	14.97
Ma20ch	-4.48%
Net CF	-69,449,000
Next Earnings Date	2026-08-10
Open	14.45
Position In Range	75
Ppne	3,422,000
Price Date	2026-05-08
Ptbv Ratio	3.72
Relative Volume	0.26x
Revenue	68,987,000x
SBC By Revenue	0.55x
Share Based Comp	382,000
Tax By Revenue	5.08x
Tr6m	-17.5%
Volume	201,977
Z Score	19.63

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/4172 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/4172 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4172?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.4%

Share of float held by funds and institutions

Insider ownership

+2.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+10.4%

Negative means the company is buying back shares.

Technical

TPEX/4172 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.6

Neutral momentum band

Price vs 200-day MA

-18.2%

50/200-day relationship not available

Beta (5Y)

0.09

Less volatile than the market

Sharpe ratio

0.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4172

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4172 stock rating?

tpex/4172 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4172 analysis?

The full report lives at /stocks/tpex/4172/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4172?

The latest report frames tpex/4172 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4172 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.